| Literature DB >> 30123578 |
Laura Iop1, Tiziana Palmosi1, Eleonora Dal Sasso1, Gino Gerosa1.
Abstract
The treatment of cardiac alterations is still nowadays a dramatic issue in the cardiosurgical practice. Synthetic materials applied in this surgery have failed in their long-term therapeutic efficacy due to low biocompatibility and compliance, especially when used in contractile sites. In order to overcome these treatment pitfalls, novel solutions have been developed based on biological tissues. Patches in pericardium, small intestinal submucosa, as well as engineered tissues of myocardium, heart valves and blood vessels have undergone a large preclinical investigation in regenerative medicine studies. Clinical translation has been started or reached by several of these new bioengineered treatment alternatives. This review will describe the preclinical and clinical experiences realized so far with the application of biological tissues in cardiovascular surgery. It will depict the progressive steps realized in the evolution of this research, as well as it will point out the challenges yet to face in order to generate the ideal biomaterial for cardiovascular repair, corrective and reconstructive surgery.Keywords: Pericardium; blood vessels; heart valves; myocardium; small intestinal submucosa
Year: 2018 PMID: 30123578 PMCID: PMC6081367 DOI: 10.21037/jtd.2018.04.27
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895